课题基金 / 基金详情

INTERFERON GAMMA (IND #BB-3368) TREATMENT OF OSTEOPETROSIS

INTERFERON GAMMA (IND #BB-3368) TREATMENT OF OSTEOPETROSIS
γ 干扰素（IND
批准号：
5222346
负责人：
L. LYNDON KEY
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5222346
关键词：
1,25 dihydroxycholecalciferol bone marrow clinical research clinical trials combination chemotherapy human subject human therapy evaluation immunotherapy interferon gamma osteopetrosis physiologic bone resorption skeletal disorder chemotherapy

项目摘要

项目成果

L. LYNDON KEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prior study has provided data suggesting that interferon gamma 1b improves ne resorption, yielding an increase in bone marrow space; improves white cell super-oxide production, and reduces the trend toward progressive narrowing the cranial nerve foramina. This study proposes to determine if interferon gam 1b therapy combined with calcitriol can improve bone turnover, marrow function and the size of cranial nerve foramina in severe osteopetrosis to a greater ext t than calcitriol alone through a randomized, controlled, open-label trial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SEARCH FOR DIABETES IN YOUTH
CLINICAL TRIAL: ALENDRONATE SODIUM IN JUVENILE OSTEOPOROSIS
ALENDRONATE SODIUM IN JUVENILE OSTEOPOROSIS
SEARCH FOR DIABETES IN YOUTH
海外基金